| 臺大學術典藏 |
2020-09-15T05:23:51Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Loh S.Y.; Reyes E.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Siswanto B.B.; Jaufeerally F.R.; KUO-LIONG CHIEN; Lee E.M.; Yeo P.S.D.; Poh K.K.; Chai P.; Wong C.C.R.; Santos J.; Yew K.L.; Narasimhan C.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Ngarmukos T.; Amin N.H.M.; Seng K.C.; Tan S.K.; Chan L.L.H.; Teo L.L.Y.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Park S.W.; Tan B.Y.; Lim C.P.; Lim A.; Noda T.; Nakajima I.; Lam C.S.P.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Uhm J.-S.; Kabuki T.; Kiuchi S.; Abidin I.Z.; Azmee M.G.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Wong C.K.; Liew H.B.; Arbain A.N.; Tan Y.Z.; Mojolou R.A.; Asnawi M.H.M.; Augustine A.-A.; Naik A.; Kaur D.; Sridevi C.; Raghu K.; Gopi A.; Sastry B.K.S.; Yu C.M.; Jin Q.; Ling T.; Li X.; Seo H.S.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Oh D.J.; Surarso R.; Danny S.S.; Martanto E.; Joung B.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Tedjokusumo P.; Purayil M.P.; Sharma M.K.; Sawhney J.; Mittal S.; Verma R.; Sethi H.J.S.; Kumar M.; Chopra V.; Kim E.J.; Tandon R.; Parikh K.; Chandarana A.; Shah U.; Park C.G.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Othman M.K.; Lee Y.W.; Yen C.H.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Lee M.H.; Park S.-M.; Roh S.-Y.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Hung C.-L.; Saharudin S.; Beh B.C.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Wu L.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators; Xie Y.; Rha S.W.; Chandavimol M.; Yingchoncharoen T.; Hsieh L.-C.; Hsu C.-H.; Lo P.-H.; Chen K.-W.; Hsiao L.-C.; Wang Y.-C.; Na J.O.; Lu C.-R.; Wu H.-P.; Chen K.; Lin Y.-N.; Chang S.-S.; Liang H.-Y.; Wu C.-H.; Lo L.-W.; Huang P.-H.; Chang S.-L.; Fan X.; Lin Y.-J.; Choi J.-I.; Leu H.-B.; Wang K.-L.; Sung S.-H.; Chao T.-F.; Yu W.-C.; Hsu C.-N.; Lin J.-W.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Shimizu W.; Kim Y.H.; KUO-LIONG CHIEN; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Kim M.; Zhang S.; Hung C.-S.; Chang S.-N.; Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I. |
| 臺大學術典藏 |
2020-08-14T03:15:30Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-08-12T06:35:40Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.;Hsu C.;Chang Y.-C.;Chong-Jen Yu;Hsu C.-H.;Lin C.-C.;Cheng A.-L.;Yang P.-C.;Yang C.-H.; Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2020-08-12T02:42:39Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Bang-Bin Chen;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; BANG-BIN CHEN; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-12T02:42:37Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Chao Y.; Hsu C.; Lee R.-C.; Lin Z.-Z.; BANG-BIN CHEN; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lin Z.-Z.;Bang-Bin Chen;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Hsu C.-H.;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C. |
| 臺大學術典藏 |
2020-08-11T08:36:51Z |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; PO-CHIN LIANG; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; Hsu C.; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-07T02:32:18Z |
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
|
Shao Y.-Y.; CHIH-HORNG WU; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-08-06T07:51:46Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-08-06T07:51:44Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2020-07-10T08:16:36Z |
Brief report: Taiwanese infants' mental and motor development - 6-24 Months
|
Wu, Y.-T.; Tsou, K.-I.; Hsu, C.-H.; Fang, L.-J.; Yao, G.; Jeng, S.-F.; KAI-PING GRACE YAO; Wu, Y.-T.; Tsou, K.-I.; Hsu, C.-H.; Fang, L.-J.; Yao, G.; Jeng, S.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Hsu C.-Y. ;Shen Y.-C. ;Chih-Wei Yu ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; CHIH-WEI YU; Hsu C.; Hu F.-C. |
| 臺大學術典藏 |
2020-07-09T02:57:02Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Chih-Wei Yu;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-03T08:45:42Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y;Chen B.-B;Da-Liang Ou;Lin Z.-Z;Hsu C.-H;Wang M.-J;Cheng A.-L;Hsu C.; Shao Y.-Y; Chen B.-B; DA-LIANG OU; Lin Z.-Z; Hsu C.-H; Wang M.-J; Cheng A.-L; Hsu C. |
| 臺大學術典藏 |
2020-07-03T02:18:23Z |
Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008
|
Hsu C.-H. ;Lu C.-Y. ;Shao P.-L. ;Lee P.-I. ;Chuan-Liang Kao ;Chung M.-Y. ;Chang L.-Y. ;Huang L.-M.; Hsu C.-H.; Lu C.-Y.; Shao P.-L.; Lee P.-I.; CHUAN-LIANG KAO; Chung M.-Y.; Chang L.-Y.; Huang L.-M. |
| 臺大學術典藏 |
2020-07-01T08:53:40Z |
Developmental function of very-low-birth-weight infants and full-term infants in early childhood
|
Fang L.-J.; Wang M.; Huang S.-H.; Chen L.-C.; Wu C.-S.; Yu S.-Y.; Kou Y.-W.; Mao S.-Y.; Hsu C.-H.; Tsou K.-S.; SUH-FANG JENG; Chen P.-S.; Chen P.-S.;Suh-Fang Jeng;Tsou K.-I.;Wang A.-H.;Hsu C.-J.;Lu L.;Hsu C.-H.;Tsou K.-S.;Fang L.-J.;Wang M.;Huang S.-H.;Chen L.-C.;Wu C.-S.;Yu S.-Y.;Kou Y.-W.;Mao S.-Y.; Lu L.; Hsu C.-J.; Wang A.-H.; Tsou K.-I. |
| 臺大學術典藏 |
2020-07-01T08:53:38Z |
Factors affecting the non-compliance for follow-up in very low birth weight children
|
Tsou K.-I.;Hsu C.-H.;Fang L.-J.;Tsou K.-S.;Suh-Fang Jeng; Tsou K.-I.; Hsu C.-H.; Fang L.-J.; Tsou K.-S.; SUH-FANG JENG |
| 臺大學術典藏 |
2020-07-01T08:53:36Z |
Brief report: Taiwanese infants' mental and motor development - 6-24 Months
|
Wu Y.-T.;Tsou K.-I.;Hsu C.-H.;Fang L.-J.;Yao G.;Suh-Fang Jeng; Wu Y.-T.; Tsou K.-I.; Hsu C.-H.; Fang L.-J.; Yao G.; SUH-FANG JENG |
| 臺大學術典藏 |
2020-07-01T08:53:36Z |
Cognitive development at age 8 years in very low birth weight children in Taiwan
|
Mu S.-C.;Tsou K.-S.;Hsu C.-H.;Fang L.-J.;Suh-Fang Jeng;Chang C.-H.;Tsou K.-I.; Mu S.-C.; Tsou K.-S.; Hsu C.-H.; Fang L.-J.; SUH-FANG JENG; Chang C.-H.; Tsou K.-I. |
| 臺大學術典藏 |
2020-07-01T08:53:36Z |
Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants
|
Suh-Fang Jeng;Hsu C.-H.;Tsao P.-N.;Chou H.-C.;Lee W.-T.;Kao H.-A.;Hung H.-Y.;Chang J.-H.;Chiu N.-C.;Hsieh W.-S.; SUH-FANG JENG; Hsu C.-H.; Tsao P.-N.; Chou H.-C.; Lee W.-T.; Kao H.-A.; Hung H.-Y.; Chang J.-H.; Chiu N.-C.; Hsieh W.-S. |
| 臺大學術典藏 |
2020-07-01T08:53:34Z |
Neonatal listeriosis in Taiwan, 1990-2007
|
Hsieh W.-S.;Tsai L.-Y.;Suh-Fang Jeng;Hsu C.-H.;Lin H.-C.;Hsueh P.-R.;Chen C.-Y.;Chou H.-C.;Tsao P.-N.;Yang P.-H.; Hsieh W.-S.; Tsai L.-Y.; SUH-FANG JENG; Hsu C.-H.; Lin H.-C.; Hsueh P.-R.; Chen C.-Y.; Chou H.-C.; Tsao P.-N.; Yang P.-H. |
| 臺大學術典藏 |
2020-07-01T08:53:33Z |
Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants
|
Wang L.-Y.;Luo H.-J.;Hsieh W.-S.;Hsu C.-H.;Hsu H.-C.;Chen P.-S.;Chiu N.-C.;Lee W.-T.;Suh-Fang Jeng; Wang L.-Y.; Luo H.-J.; Hsieh W.-S.; Hsu C.-H.; Hsu H.-C.; Chen P.-S.; Chiu N.-C.; Lee W.-T.; SUH-FANG JENG |
| 臺大學術典藏 |
2020-07-01T08:53:27Z |
A randomized controlled trial of clinic-based and home-based interventions in comparison with usual care for preterm infants: Effects and mediators
|
Wu Y.-C.;Leng C.-H.;Hsieh W.-S.;Hsu C.-H.;Chen W.J.;Gau S.S.F.;Chiu N.-C.;Yang M.-C.;Li-Jung Fang, Hsu H.-C.;Yu Y.-T.;Wu Y.-T.;Chen L.-C.;Suh-Fang Jeng; Wu Y.-C.; Leng C.-H.; Hsieh W.-S.; Hsu C.-H.; Chen W.J.; Gau S.S.F.; Chiu N.-C.; Yang M.-C.; Li-Jung Fang, Hsu H.-C.; Yu Y.-T.; Wu Y.-T.; Chen L.-C.; SUH-FANG JENG |
| 臺大學術典藏 |
2020-07-01T08:53:24Z |
Family-centered care improved neonatal medical and neurobehavioral outcomes in preterm infants: Randomized controlled trial
|
Yu Y.-T.;Hsieh W.-S.;Hsu C.-H.;Lin Y.-J.;Lin C.-H.;Hsieh S.;Lu L.;Cherng R.-J.;Chang Y.-J.;Fan P.-C.;Yao N.-J.;Chen W.J.;Suh-Fang Jeng; Yu Y.-T.; Hsieh W.-S.; Hsu C.-H.; Lin Y.-J.; Lin C.-H.; Hsieh S.; Lu L.; Cherng R.-J.; Chang Y.-J.; Fan P.-C.; Yao N.-J.; Chen W.J.; SUH-FANG JENG |
| 臺大學術典藏 |
2020-06-30T08:09:55Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Huang Y.-H.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Hsu C.-H.;Kang-Yi Su;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Yang T.-Y.;Chang G.-C.; Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; KANG-YI SU; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T03:22:28Z |
Reliability of the assessment of mother-infant sensitivity-Chinese version for preterm and term taiwanese mother-infant dyads
|
Hsu H.-C.; Wang L.-Y.; Jeng S.-F.; Hsu C.-H.; Yu Y.-T.; Hsieh W.-S.; Lin U.-C.; YEN-TZU WU; Yen-Tzu Wu;Lin U.-C.;Yu Y.-T.;Hsieh W.-S.;Hsu C.-H.;Hsu H.-C.;Wang L.-Y.;Jeng S.-F. |
| 臺大學術典藏 |
2020-06-30T03:22:26Z |
A randomized controlled trial of clinic-based and home-based interventions in comparison with usual care for preterm infants: Effects and mediators
|
Wu Y.-C.;Leng C.-H.;Hsieh W.-S.;Hsu C.-H.;Chen W.J.;Gau S.S.F.;Chiu N.-C.;Yang M.-C.;Li-Jung Fang, Hsu H.-C.;Yu Y.-T.;Yen-Tzu Wu;Chen L.-C.;Jeng S.-F.; Wu Y.-C.; Leng C.-H.; Hsieh W.-S.; Hsu C.-H.; Chen W.J.; Gau S.S.F.; Chiu N.-C.; Yang M.-C.; Li-Jung Fang, Hsu H.-C.; Yu Y.-T.; YEN-TZU WU; Chen L.-C.; Jeng S.-F. |
| 臺大學術典藏 |
2020-06-29T02:20:06Z |
Neonatal respiratory status predicts longitudinal respiratory health outcomes in preterm infants
|
Hsu C.-H.; Peng S.; Jeng S.-F.; Luo H.-J.;Li-Ying Wang;Chen P.-S.;Hsieh W.-S.;Hsu C.-H.;Peng S.;Jeng S.-F.; Luo H.-J.; LI-YING WANG; Chen P.-S.; Hsieh W.-S. |
| 臺大學術典藏 |
2020-06-29T02:04:13Z |
Developmental function of very-low-birth-weight infants and full-term infants in early childhood
|
Chen P.-S.;Jeng S.-F.;Tsou K.-I.;Wang A.-H.;Hsu C.-J.;Lu L.;Hsu C.-H.;Tsou K.-S.;Fang L.-J.;Wang M.;Huang S.-H.;Li-Chiou Chen;Wu C.-S.;Yu S.-Y.;Kou Y.-W.;Mao S.-Y.; Chen P.-S.; Jeng S.-F.; Tsou K.-I.; Wang A.-H.; Hsu C.-J.; Lu L.; Hsu C.-H.; Tsou K.-S.; Fang L.-J.; Wang M.; Huang S.-H.; LI-CHIOU CHEN; Wu C.-S.; Yu S.-Y.; Kou Y.-W.; Mao S.-Y. |
| 臺大學術典藏 |
2020-06-29T02:04:08Z |
The effect of in-hospital developmental care on neonatal morbidity, growth and development of preterm Taiwanese infants: A randomized controlled trial
|
LI-CHIOU CHEN; Wu Y.-C.; Hsieh W.-S.; Hsu C.-H.; Leng C.-H.; Chen W.J.; Chiu N.-C.; Lee W.-T.; Yang M.C.; Fang L.-J.; Hsu H.-C.; Jeng S.-F.; Li-Chiou Chen;Wu Y.-C.;Hsieh W.-S.;Hsu C.-H.;Leng C.-H.;Chen W.J.;Chiu N.-C.;Lee W.-T.;Yang M.C.;Fang L.-J.;Hsu H.-C.;Jeng S.-F. |
| 臺大學術典藏 |
2020-06-18T06:10:32Z |
Improved broadband and quasi-omnidirectional anti-reflection properties with biomimetic silicon nanostructures
|
Jen, Y.-J.; Peng, C.-Y.; Liu, T.-A.; Hsu, Y.-K.; Pan, C.-L.; Lo, H.-C.; Hsu, C.-H.; Chang, Y.-H.; Lee, C.-S.; Chen, K.-H.; Chen, L.-C.; Chattopadhyay, S.; Huang, Y.-F.; Chen, L.-C.;Chen, K.-H.;Lee, C.-S.;Chang, Y.-H.;Hsu, C.-H.;Lo, H.-C.;Pan, C.-L.;Hsu, Y.-K.;Liu, T.-A.;Peng, C.-Y.;Jen, Y.-J.;Chattopadhyay, S.;Huang, Y.-F. |
| 臺大學術典藏 |
2020-06-17T03:01:30Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Huang Y.-H.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Hsu C.-H.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Sung-Liang Yu;Yang T.-Y.;Chang G.-C.; Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; SUNG-LIANG YU; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-16T07:53:41Z |
Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy
|
Ou D.-L.;Chen C.-L.;Lin S.B.;Hsu C.-H.;Liang-In Lin; Ou D.-L.; Chen C.-L.; Lin S.B.; Hsu C.-H.; LIANG-IN LIN |
| 臺大學術典藏 |
2020-06-16T06:31:39Z |
A DAG-based algorithm for obstacle-aware topology-matching on-track bus routing
|
Hsu, C.-H.;Hungz, S.-C.;Chenz, H.;Sunz, F.-K.;Chang, Y.-W.; Hsu, C.-H.; Hungz, S.-C.; Chenz, H.; Sunz, F.-K.; Chang, Y.-W.; YAO-WEN CHANG |
| 臺大學術典藏 |
2020-06-11T06:41:23Z |
MagMobile: Enhancing Social Interactions with Rapid View-Stitching Games of Mobile Devices
|
Huang, D.-Y.;Chang, T.-W.;Tsai, M.-L.;Lin, C.-P.;Yu, N.-H.;Chen, M.Y.;Hung, Y.-P.;Hsu, C.-H.; Huang, D.-Y.; Chang, T.-W.; Tsai, M.-L.; Lin, C.-P.; Yu, N.-H.; Chen, M.Y.; Hung, Y.-P.; Hsu, C.-H.; YI-PING HUNG |
| 臺大學術典藏 |
2020-06-11T06:12:47Z |
GasStation: Power and area efficient buffering for multiple power domain design
|
Lu, C.-P.;Jiang, I.H.-R.;Hsu, C.-H.; Lu, C.-P.; Jiang, I.H.-R.; Hsu, C.-H.; HUI-RU JIANG |
| 臺大學術典藏 |
2020-06-04T07:50:38Z |
A novel fabrication of fiber Bragg grating in hollow-core fiber with HPDLCs
|
LON A. WANG; Hsu, C.-H.;Choi, W.-K.;Wang, L.A.; Hsu, C.-H.; Choi, W.-K.; Wang, L.A. |
| 臺大學術典藏 |
2020-06-04T07:50:37Z |
Feasibility study on fabricating an in-line wavelength tunable filter based on polymer-dispersed liquid crystal
|
Hsu, C.-H.;Choi, W.-K.;Wang, L.A.; Hsu, C.-H.; Choi, W.-K.; Wang, L.A.; LON A. WANG |
| 臺大學術典藏 |
2020-05-26T09:27:31Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H;Cheng A.-L;Hsu C;Chih-Hsin Yang;Lu Y.-S;Lin C.-C;Bu C.-F;Yeh K.-H.; Hsu C.-H; Cheng A.-L; Hsu C; CHIH-HSIN YANG; Lu Y.-S; Lin C.-C; Bu C.-F; Yeh K.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C;Shen Y.-C;Chih-Hsin Yang;Yeh K.-H;Lu Y.-S;Hsu C.-H;Liu H.-T;Li C.-C;Chen J.-S;Wu C.-Y;Cheng A.-L.; Hsu C; Shen Y.-C; CHIH-HSIN YANG; Yeh K.-H; Lu Y.-S; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu Y.-S;Hsu C;Li C.-C;Kuo S.-H;Yeh K.-H;Chih-Hsin Yang;Hsu C.-H;Wu C.-Y;Cheng A.-L.; Lu Y.-S; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; CHIH-HSIN YANG; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Lu Y.S;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Chih-Hsin Yang;Cheng A.L.; Yeh K.H; Lu Y.S; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; CHIH-HSIN YANG; Cheng A.L. |
| 臺大學術典藏 |
2020-05-26T09:27:28Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Chih-Hsin Yang;Chen M.-C;Cheng A.-L;Hsu C.-H;Yeh K.-H;Yu Y.-C;Whang-Peng J;Yang P.-C.; CHIH-HSIN YANG; Chen M.-C; Cheng A.-L; Hsu C.-H; Yeh K.-H; Yu Y.-C; Whang-Peng J; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:26Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Hsu C.-H; Cheng J.C; Wang H.-P; Lee J.-M; Yeh K.-H; CHIH-HSIN YANG; Lin J.-T; Cheng A.-L; Lee Y.-C.; Lin C.-C;Hsu C.-H;Cheng J.C;Wang H.-P;Lee J.-M;Yeh K.-H;Chih-Hsin Yang;Lin J.-T;Cheng A.-L;Lee Y.-C.; Lin C.-C |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C;Yeh K.-H;Chih-Hsin Yang;Hsu C;Tsai Y.-C;Hsu W.-L;Cheng A.-L;Hsu C.-H.; Lin C.-C; Yeh K.-H; CHIH-HSIN YANG; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C;Cheng A.-L;Hsu C.-H;Lu Y.-S;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Chih-Hsin Yang; Lin C.-C; Cheng A.-L; Hsu C.-H; Lu Y.-S; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial
|
Lin C.-C; Hsu C; Hsu C.-H; Hsu W.-L; Cheng A.-L; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma
|
Chih-Hsin Yang;Cheng A.-L;Keng H.-Y;Hsu C.-H;Pu Y.-S;Lin C.-C; Lin C.-C; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:06Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
Chengb A.-L.;Hsu C.-H;Hong R.-L;Chih-Hsin Yang;Chang D.-Y;Shao Y.-Y;Hu F.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C; Hu F.-C; Shao Y.-Y; Chang D.-Y; CHIH-HSIN YANG; Hong R.-L; Hsu C.-H; Chengb A.-L. |
